Litcius/Paper detail

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study

Qinghe Zeng, Christophe Klein, Stefano Caruso, Pascale Maille, Daniela Allende, Beatriz Mínguez, Massimo Iavarone, Massih Ningarhari, Andrea Casadei-Gardini, Federica Pedica, Margherita Rimini, Riccardo Perbellini, Camille Boulagnon‐Rombi, Alexandra Heurgué, Marco Maggioni, Mohamed Rela, Mukul Vij, Sylvain Baulande, Patricia Legoix, Sonia Lameiras, Daniela Allende, Giuliana Amaddeo, Josepmaria Argemi, Sylvain Baulande, Aurélie Bèaufrere, María Bermúdez-Ramos, Camille Boulagnon‐Rombi, Jérôme Boursier, Léa Bruges, Julien Caldéraro, Julien Calderaro, Stefano Caruso, Stefano Caruso, A. García, Stephen L. Chan, Stephen Lam Chan, Antonio D'Alessio, Alba Díaz, Antonia Digklia, Jean‐François Dufour, Jean-François Dufour, Narmin Ghaffari Laleh, Narmin Ghaffari Laleh, Purva Gopal, Rondell P. Graham, Alexandra Heurgué, Massimo Iavarone, Mercedes Iñarrairaegui, Jakob Nikolas Kather, Jakob Nikolas Kather, Ismaïl Labgaa, Sonia Lameiras, Patricia Legoix, Marie Lequoy, Howard H.W. Leung, Howard Ho-Wai Leung, Marco Maggioni, Marco Maggioni, Juan Ignacio Marín, Guillermo Mendoza-Pacas, Sophie Michalak, Beatriz Mínguez, Omar S. M. El Nahhas, Omar S M El Nahhas, Pooja Navale, Massih Ningarhari, Massih Ningarhari, Valérie Paradis, Jean–Michel Pawlotsky, Jean-Michel Pawlotsky, Riccardo Perbellini, Riccardo Perbellini, Simon Peter, David James Pinato, Pompilia Radu, Hélène Regnault, María Reig, Maria Reig, Mohamed Rela, Lorenza Rimassa, Margherita Rimini, María Teresa Salcedo, María Teresa Salcedo, Bruno Sangro, Christine Sempoux, Tung‐Hung Su, Callie Torres, Nguyen H. Tran, Eric Trépo, Marı́a Varela, Gontran Verset, Gontran Verset, Arndt Vogel, Dominique Wendum, Qinghe Zeng, Qinghe Zeng, Marianne Ziol, Léa Bruges, Viviane Gnemmi, Jean-Charles Nault

2023The Lancet Oncology109 citationsDOIOpen Access PDF

Topics & Concepts

AtezolizumabBevacizumabMedicineOncologyHepatocellular carcinomaBiomarkerInternal medicinePathologyCancerChemotherapyImmunotherapyNivolumabBiologyBiochemistryHepatocellular Carcinoma Treatment and PrognosisFerroptosis and cancer prognosisCancer Immunotherapy and Biomarkers